Hospital
Baptist Hospitals of Southeast Texas
Baptist Hospitals of Southeast Texas was paid $15.22M by Medicaid between Dec 2019 and Dec 2024, across 134 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.
33Billing provider infoBAPTIST HOSPITALS OF SOUTHEAST TEXAS
BEAUMONT, TX 77701
BEAUMONT, TX 77701
33aNPI1093744187assigned 07/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.22M
24GClaims320,692
24DCodes billed134
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#8 of 109
Median peer was paid$1.15M
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 26 | $101.50 | |
| 2020 | 10,124 | $487K | |
| 2021 | 77,705 | $3.14M | |
| 2022 | 99,435 | $4.15M | |
| 2023 | 85,906 | $4.98M | |
| 2024incomplete | 47,496 | $2.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 22,517 | 21,365 | $5.19M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 7,635 | 7,086 | $1.99M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.2% | 19,706 | 18,990 | $1.24M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.9% | 13,992 | 13,587 | $743K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.2% | 10,358 | 10,044 | $642K |
| 71045 | Radiologic examination, chest; single view | 4.0% | 13,935 | 13,281 | $616K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.6% | 5,693 | 5,083 | $548K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 2,855 | 2,713 | $363K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 33,243 | 27,611 | $319K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 4,771 | 4,654 | $252K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.5% | 3,517 | 2,799 | $228K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 7,470 | 7,300 | $225K |
122 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 3,734 | $217K |
| 80053 | Comprehensive metabolic panel | 1.3% | 15,308 | $200K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 4,379 | $176K |
| 86703 | 1.0% | 8,620 | $153K | |
| 80047 | <1% | 9,288 | $152K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 554 | $151K |
| 84702 | <1% | 5,933 | $143K | |
| G0378 | Hospital observation service, per hour | <1% | 1,149 | $134K |
| 76801 | <1% | 696 | $107K | |
| 86803 | <1% | 5,790 | $88K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,019 | $80K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 155 | $69K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,564 | $64K |
| 97597 | <1% | 1,237 | $61K | |
| 81001 | <1% | 12,729 | $58K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 516 | $55K |
| 87420 | <1% | 2,094 | $53K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 944 | $51K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,494 | $48K |
| 80076 | <1% | 4,314 | $42K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 604 | $39K |
| 87081 | <1% | 3,657 | $39K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 29 | $39K |
| 83690 | <1% | 4,419 | $37K | |
| 84484 | <1% | 3,440 | $37K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 727 | $34K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,599 | $30K |
| 82728 | <1% | 1,856 | $25K | |
| 82550 | <1% | 4,181 | $24K | |
| 85014 | <1% | 7,339 | $22K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 761 | $22K |
| 83880 | <1% | 1,326 | $22K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,367 | $17K |
| 87040 | <1% | 1,162 | $17K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 197 | $17K |
| 82553 | <1% | 2,450 | $17K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,848 | $17K |
| 82805 | <1% | 418 | $17K | |
| 87428 | <1% | 606 | $16K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,051 | $15K |
| 83550 | <1% | 1,662 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 342 | $13K |
| 80061 | Lipid panel | <1% | 1,341 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 388 | $11K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 948 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 96 | $10K |
| J0897 | Injection, denosumab, 1 mg | <1% | 39 | $9K |
| 86769 | <1% | 187 | $9K | |
| 81003 | <1% | 3,123 | $9K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 45 | $7K |
| 80306 | <1% | 349 | $7K | |
| 83735 | <1% | 1,934 | $7K | |
| 84703 | <1% | 822 | $7K | |
| 86901 | <1% | 2,436 | $7K | |
| 86900 | <1% | 2,435 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 142 | $7K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 148 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 809 | $6K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,076 | $5K |
| 74018 | <1% | 167 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $5K |
| 82607 | <1% | 338 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 670 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 703 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 126 | $5K |
| 86885 | <1% | 1,181 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,142 | $4K |
| 76641 | <1% | 28 | $3K | |
| 87088 | <1% | 649 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,179 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $3K |
| 85610 | <1% | 1,134 | $3K | |
| 85730 | <1% | 878 | $3K | |
| 36600 | <1% | 174 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 58 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 395 | $2K |
| 83605 | <1% | 295 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 444 | $2K |
| 82746 | <1% | 127 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 89 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 32 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 22 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 17 | $1K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 72 | $1K |
| 86300 | <1% | 85 | $1K | |
| 87340 | <1% | 71 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,808 | $1K |
| 84439 | <1% | 258 | $987.92 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 810 | $844.66 |
| 94664 | <1% | 208 | $822.41 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 66 | $782.71 |
| 72110 | <1% | 12 | $719.50 | |
| 87186 | <1% | 153 | $689.17 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 310 | $516.08 |
| 86593 | <1% | 70 | $492.42 | |
| 71250 | <1% | 13 | $363.57 | |
| 84030 | <1% | 37 | $346.91 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,082 | $304.37 |
| 96415 | <1% | 28 | $279.77 | |
| 83520 | <1% | 46 | $274.68 | |
| 82565 | <1% | 147 | $233.08 | |
| 80321 | <1% | 12 | $190.23 | |
| 85379 | <1% | 26 | $157.02 | |
| 94760 | <1% | 46 | $153.26 | |
| 87070 | <1% | 39 | $131.76 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 28 | $116.61 |
| 83615 | <1% | 33 | $115.78 | |
| 85652 | <1% | 37 | $103.74 | |
| 84100 | <1% | 32 | $69.16 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 30 | $40.59 |
| 86140 | <1% | 27 | $33.15 | |
| 82272 | <1% | 13 | $32.80 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,047 | $30.90 |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,942 | $14.78 |
| 87075 | <1% | 13 | $7.95 | |
| 82962 | <1% | 1,527 | $5.37 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 160 | $3.03 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 663 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 29 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 106 | $0.00 |
| J3490 | Unclassified drugs | 0% | 127 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOSS, JUSTIN (CEO)